Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Observed Mean Plot: eGFR (mL/min/1.73m2) by Week in FLOW Trial Observed data from the in-trial period until week 104
[13] Zhao H, Alam A, Chen Q, A Eusman M, Pal A, Eguchi S, Wu L, Ma D
Since the lack of insurance coverage for GLP-1s creates a barrier for T1D patients, researchers are hopeful that studies like the Phase 2 trial of CT-868 will pave the way for more on-label approvals in the type 1 diabetes community
Healing the damage that chronic inflammation has caused
This sequential approach serves two purposes: first, to eliminate immortal time bias by properly aligning treatment initiation with follow-up start (T0) and, second, to maximize statistical power by allowing individuals to contribute data across multiple trials
US$ 26.77
US$ 24.17
US$ 21.05
US$ 20.01
US$ 28.92
US$ 24.41
US$ 21.95
US$ 29.68
US$ 21.40
US$ 28.21
US$ 22.30
